Adcirca 20 MG Oral Tablet

RxCUI
849866
RxNorm name
Adcirca 20 MG Oral Tablet
Display name
Adcirca 20 MG Oral Tablet
Full name
Adcirca 20 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ADCIRCATADALAFILUnited Therapeutics Corporationff61b237-be8e-461b-8114-78c52a8ad0ae2025-12-15Warnings, Adverse reactionsExact identifier
rxcui: 849866

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ff61b237-be8e-461b-8114-78c52a8ad0aeadcirca 20 MG Oral Tablet [PSN] · Pulmonary Hypertension tadalafil 20 MG Oral Tablet [Adcirca] [SBD] · Adcirca 20 MG Oral Tablet [SY] · Adcirca 20 MG Pulmonary Hypertension Oral Tablet [SY]434These highlights do not include all the information needed to use ADCIRCA safely and effectively. See full prescribing information for ADCIRCA. ADCIRCA (tadalafil) tablets for oral administration Initial U.S. Approval: 200320251215
3ca3928a-6466-4290-a228-461fa8a91735adcirca 20 MG Oral Tablet [PSN] · Pulmonary Hypertension tadalafil 20 MG Oral Tablet [Adcirca] [SBD] · Adcirca 20 MG Oral Tablet [SY] · Adcirca 20 MG Pulmonary Hypertension Oral Tablet [SY]43These highlights do not include all the information needed to use ADCIRCA safely and effectively. See full prescribing information for ADCIRCA. ADCIRCA (tadalafil) tablets for oral administration Initial U.S. Approval: 200320191217